GenomOncology Organization
GenomOncology enables precision medicine by translating next generation sequencing data into actionable information.
Investors Number:
4
Estimated Revenue:
$1M to $10M
Headquarters:
Others
Investor Type:
Healthcare Company
Total Funding:
$2.9M
Last Funding Type:
Debt Financing
Founded Date:
2012
Technology:
Genetics/Genomics
Industry:
Gene Therapies (disease treatment)
Employee Number:
11-50